Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 132, Issue 20
November 15 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

Lymphoid Neoplasia
Do you know TAFRO?
Matthew A. Lunning,James O. Armitage
View Articletitled, Do you know TAFRO?
Lymphoid Neoplasia
Knick-knack PADIMAC
Brian A. Walker
View Articletitled, Knick-knack PADIMAC
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
Charcot-Leyden crystals: solving an enigma
Amy D. Klion
View Articletitled, Charcot-Leyden crystals: solving an enigma
TRANSPLANTATION
Int“Dll”igent control of T-cell pathology in GVHD
Markus Düchler
View Articletitled, Int“Dll”igent control of T-cell pathology in GVHD

SPECIAL REPORT

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
Clinical Trials & Observations
Frits van Rhee,Peter Voorhees,Angela Dispenzieri,Alexander Fosså,Gordan Srkalovic,Makoto Ide,Nikhil Munshi,Stephen Schey,Matthew Streetly,Sheila K. Pierson,Helen L. Partridge,Sudipto Mukherjee,Dustin Shilling,Katie Stone,Amy Greenway,Jason Ruth,Mary Jo Lechowicz,Shanmuganathan Chandrakasan,Raj Jayanthan,Elaine S. Jaffe,Heather Leitch,Naveen Pemmaraju,Amy Chadburn,Megan S. Lim,Kojo S. Elenitoba-Johnson,Vera Krymskaya,Aaron Goodman,Christian Hoffmann,Pier Luigi Zinzani,Simone Ferrero,Louis Terriou,Yasuharu Sato,David Simpson,Raymond Wong,Jean-Francois Rossi,Sunita Nasta,Kazuyuki Yoshizaki,Razelle Kurzrock,Thomas S. Uldrick,Corey Casper,Eric Oksenhendler,David C. Fajgenbaum
View Articletitled, International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
Supplemental data

REVIEW ARTICLES

Molecular monitoring in CML: how deep? How often? How should it influence therapy?
Naranie Shanmuganathan,Timothy P. Hughes
View Articletitled, Molecular monitoring in CML: how deep? How often? How should it influence therapy?
Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist
Sarah H. O’Brien
View Articletitled, Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist

CLINICAL TRIALS AND OBSERVATIONS

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
CME Clinical Trials & Observations
Matthieu Jestin,Ygal Benhamou,An-Sofie Schelpe,Elien Roose,François Provôt,Lionel Galicier,Miguel Hié,Claire Presne,Pascale Poullin,Alain Wynckel,Samir Saheb,Christophe Deligny,Aude Servais,Stéphane Girault,Yahsou Delmas,Tarik Kanouni,Alexandre Lautrette,Dominique Chauveau,Christiane Mousson,Pierre Perez,Jean-Michel Halimi,Anne Charvet-Rumpler,Mohamed Hamidou,Pascal Cathébras,Karen Vanhoorelbeke,Agnès Veyradier,Paul Coppo,on behalf of the French Thrombotic Microangiopathies Reference Center
View Articletitled, Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
Supplemental data

LYMPHOID NEOPLASIA

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
Michael A. Chapman,Jonathan Sive,John Ambrose,Claire Roddie,Nicholas Counsell,Anna Lach,Mahnaz Abbasian,Rakesh Popat,Jamie D. Cavenagh,Heather Oakervee,Matthew J. Streetly,Stephen Schey,Mickey Koh,Fenella Willis,Andres E. Virchis,Josephine Crowe,Michael F. Quinn,Gordon Cook,Charles R. Crawley,Guy Pratt,Mark Cook,Nivette Braganza,Toyin Adedayo,Paul Smith,Laura Clifton-Hadley,Roger G. Owen,Pieter Sonneveld,Jonathan J. Keats,Javier Herrero,Kwee Yong
View Articletitled, RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
Supplemental data
IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos
Pasquale L. Fedele,Simon N. Willis,Yang Liao,Michael S. Low,Jai Rautela,David H. Segal,Jia-Nan Gong,Nicholas D. Huntington,Wei Shi,David C. S. Huang,George Grigoriadis,Julie Tellier,Stephen L. Nutt
View Articletitled, IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos
Supplemental data
miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients
Brief Report
Veronica Balatti,Luisa Tomasello,Laura Z. Rassenti,Dario Veneziano,Giovanni Nigita,Huan-You Wang,John A. Thorson,Thomas J. Kipps,Yuri Pekarsky,Carlo M. Croce
View Articletitled, <em>miR-125a</em> and <em>miR-34a</em> expression predicts Richter syndrome in chronic lymphocytic leukemia patients
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death
Clinical Trials & Observations Brief Report
Shigeharu Ueki,Takahiro Tokunaga,Rossana C. N. Melo,Hidekazu Saito,Kohei Honda,Mineyo Fukuchi,Yasunori Konno,Masahide Takeda,Yohei Yamamoto,Makoto Hirokawa,Shigeharu Fujieda,Lisa A. Spencer,Peter F. Weller
View Articletitled, Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death
Supplemental data

TRANSPLANTATION

Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice
Vedran Radojcic,Katelyn Paz,Jooho Chung,Jing Du,Eric T. Perkey,Ryan Flynn,Sanja Ivcevic,Michael Zaiken,Ann Friedman,Minhong Yan,Maria A. Pletneva,Stefanie Sarantopoulos,Christian W. Siebel,Bruce R. Blazar,Ivan Maillard

There is a Blood Commentary on this article in this issue.

View Articletitled, Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice
Supplemental data

LETTERS TO BLOOD

Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms
James A. Kennedy,Jessie J. F. Medeiros,Stephanie M. Dobson,Andrea Arruda,Mahadeo A. Sukhai,Tracy Stockley,Anne Tierens,Mark D. Minden,Suzanne Kamel-Reid,John E. Dick,Vikas Gupta
View Articletitled, Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms
Supplemental data
Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia
Clinical Trials & Observations
Adrianna Vlachos,Philip S. Rosenberg,Eva Atsidaftos,Jessica Kang,Kenan Onel,Ravi N. Sharaf,Blanche P. Alter,Jeffrey M. Lipton
View Articletitled, Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia

BLOOD WORK

Acquired α-thalassemia associated with myelodysplastic syndromes
Shantelle Mullen,Dipti Talaulikar
View Articletitled, Acquired α-thalassemia associated with myelodysplastic syndromes

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Rituximab prevents long-term relapses in TTP
CME
View Articletitled, Rituximab prevents long-term relapses in TTP
All Issues

Advertisement intended for health care professionals

Preclinical efficacy of potent and selective menin-KMT2A inhibitor JNJ-75276617 in KMT2A- and NPM1-altered leukemias
Genotype-Phenotype Correlations in Chronic Granulomatous Disease: Insights From a Large National Cohort
GVHD targets organoid-forming bile duct stem cells via a TGF-β-dependent manner
Quadriparesis and paraparesis following chimeric antigen receptor T-cell (CART) therapy in children and adolescents
How I Treat on Infant Acute Lymphoblastic Leukemia

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals